“…The use of immobilized biocatalysts confers many advantages (enhanced stability, robust reusability, simplified downstream processing, etc.) over purified enzymes in many bioconversion processes. , Carrier-free immobilized enzymes, particularly cross-linked enzyme aggregates (CLEAs), have attracted extensive attention due to their high enzyme activity, good specificity, low production cost, and easy handling when compared with conventionally immobilized enzymes (carrier bound and encapsulation/entrapment). , Generally, the preparation of CLEAs often involves the precipitation/aggregation of soluble enzymes (not necessarily in a pure form) by inorganic salts, organic solvents, or nonionic polymers, followed by cross-linking of the resulting enzyme aggregates, Figure . ,, However, a potential drawback of such a method is that alteration of enzyme configuration might occur during the aggregation and cross-linking processes, which may eventually lead to reduced enzyme activity. , This drawback can be overcome by aggregating and cross-linking the soluble enzymes in the presence of certain protective additives such as bovine serum albumin (BSA) − or sugars. , In recent years, the CLEAs technique has been successfully applied to a broad range of enzymes, including acylase, α-amylase, laccase, β-galactosidase, etc. ,,, However, there is only one report on synthesizing lactulose by CLEAs of β-galactosidase in repeated-batch operation …”